Imperial College London

Activities: Training & Education

Trending Articles

  1. Counteracting counterfeits in the pharmaceutical supply chain Sreedhar Patnala, General Manager at Systech, discusses the comprehensive benefits of embracing traceability
  2. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Industrial data mastery: navigating the 2025 landscape As industrial manufacturers contend with the ever-increasing volume and variety of operational data, the year ahead promises both complexity and opportunity
  4. Novo Holdings completes acquisition of Catalent Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
  5. ACG expands global footprint with new capsule manufacturing facility in Thailand New capsule manufacturing facility in Rayong, Thailand, is strategically positioned to serve key Asian markets

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Finance

Liverpool and Imperial College London to lead UK’s flagship £12m AI for Chemistry Hub

The University of Liverpool and Imperial College London will lead a £12 million research hub to develop AI for Chemistry, thanks to investment from the Engineering & Physical Sciences Research Council (EPSRC) and consortium partners
Manufacturing

Imperial spin-out launches robotic COVID-19 PCR-based tests

Salient Bio was founded by former team members of Imperial College’s London BioFoundry, which accelerates the commercialisation of synthetic biology research and technology
Media

Heptares enters drug collaboration with Imperial

Heptares, the wholly-owned subsidiary of Sosei Group Corporation, has entered a new drug research and development collaboration with Imperial College London
Manufacturing

Abzena develops new facilities in Cambridge, UK and San Diego

Abzena, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, provides an update on its UK and US facilities
Research & Development

Domainex expands partnership with ICL to reduce heart muscle damage during heart attacks

The aim is to discover a drug that inhibits the enzyme MAP4K4, which plays a key role in triggering cell death following a heart attack
Infection Control

Study calls for strategy to fight multidrug-resistant TB in migrants

Paper recommends improved access to services, more consistent pan-European protocols for screening and treatment, and further research to document the level of MDR-TB infection in the European migrant population
Research & Development

Global research network hunts the missing link between genetics and environmental factors to unlock the secrets of global diseases

A new global network linking leading research centres across the world has launched today to tackle some of the most pressing global health challenges of our time such as autism, cancer, diabetes and dementia.
Subscribe now